154 related articles for article (PubMed ID: 34110341)
1. Quantifying nanotherapeutic penetration using a hydrogel-based microsystem as a new 3D
Goodarzi S; Prunet A; Rossetti F; Bort G; Tillement O; Porcel E; Lacombe S; Wu TD; Guerquin-Kern JL; Delanoë-Ayari H; Lux F; Rivière C
Lab Chip; 2021 Jun; 21(13):2495-2510. PubMed ID: 34110341
[TBL] [Abstract][Full Text] [Related]
2. Light sheet fluorescence microscopy versus confocal microscopy: in quest of a suitable tool to assess drug and nanomedicine penetration into multicellular tumor spheroids.
Lazzari G; Vinciguerra D; Balasso A; Nicolas V; Goudin N; Garfa-Traore M; Fehér A; Dinnyés A; Nicolas J; Couvreur P; Mura S
Eur J Pharm Biopharm; 2019 Sep; 142():195-203. PubMed ID: 31228557
[TBL] [Abstract][Full Text] [Related]
3. Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles.
Lu H; Stenzel MH
Small; 2018 Mar; 14(13):e1702858. PubMed ID: 29450963
[TBL] [Abstract][Full Text] [Related]
4. Predicting nanocarriers' efficacy in 3D models with Brillouin microscopy.
Guerriero G; Viel A; Feltri V; Balboni A; Yan G; Monnier S; Lollo G; Dehoux T
Nanoscale; 2023 Dec; 15(47):19255-19267. PubMed ID: 37990811
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer triple co-culture spheroid model to assess the biocompatibility and anticancer properties of polymeric nanoparticles.
Bauleth-Ramos T; Feijão T; Gonçalves A; Shahbazi MA; Liu Z; Barrias C; Oliveira MJ; Granja P; Santos HA; Sarmento B
J Control Release; 2020 Jul; 323():398-411. PubMed ID: 32320816
[TBL] [Abstract][Full Text] [Related]
6. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
[TBL] [Abstract][Full Text] [Related]
7. Two-Photon Microscopy Analysis of Gold Nanoparticle Uptake in 3D Cell Spheroids.
Rane TD; Armani AM
PLoS One; 2016; 11(12):e0167548. PubMed ID: 27936027
[TBL] [Abstract][Full Text] [Related]
8. Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model.
Sokolova V; Nzou G; van der Meer SB; Ruks T; Heggen M; Loza K; Hagemann N; Murke F; Giebel B; Hermann DM; Atala AJ; Epple M
Acta Biomater; 2020 Jul; 111():349-362. PubMed ID: 32413579
[TBL] [Abstract][Full Text] [Related]
9. A method for reproducible high-resolution imaging of 3D cancer cell spheroids.
Phillips TA; Caprettini V; Aggarwal N; Marcotti S; Tetley R; Mao Y; Shaw T; Chiappini C; Parsons M; Cox S
J Microsc; 2023 Jul; 291(1):30-42. PubMed ID: 36639864
[TBL] [Abstract][Full Text] [Related]
10. Tumor stroma-containing 3D spheroid arrays: A tool to study nanoparticle penetration.
Priwitaningrum DL; Blondé JG; Sridhar A; van Baarlen J; Hennink WE; Storm G; Le Gac S; Prakash J
J Control Release; 2016 Dec; 244(Pt B):257-268. PubMed ID: 27616660
[TBL] [Abstract][Full Text] [Related]
11. Agarose Micro-Well Platform for Rapid Generation of Homogenous 3D Tumor Spheroids.
Krishnan MA; Yadav K; Chelvam V
Curr Protoc; 2021 Jul; 1(7):e199. PubMed ID: 34288582
[TBL] [Abstract][Full Text] [Related]
12. Spatio-temporal analysis of nanoparticles in live tumor spheroids impacted by cell origin and density.
Ahmed-Cox A; Pandzic E; Johnston ST; Heu C; McGhee J; Mansfeld FM; Crampin EJ; Davis TP; Whan RM; Kavallaris M
J Control Release; 2022 Jan; 341():661-675. PubMed ID: 34915071
[TBL] [Abstract][Full Text] [Related]
13. Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies.
Ong SM; Zhao Z; Arooz T; Zhao D; Zhang S; Du T; Wasser M; van Noort D; Yu H
Biomaterials; 2010 Feb; 31(6):1180-90. PubMed ID: 19889455
[TBL] [Abstract][Full Text] [Related]
14. Optimising non-viral gene delivery in a tumour spheroid model.
Mellor HR; Davies LA; Caspar H; Pringle CR; Hyde SC; Gill DR; Callaghan R
J Gene Med; 2006 Sep; 8(9):1160-70. PubMed ID: 16807955
[TBL] [Abstract][Full Text] [Related]
15. Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment.
Le Duc G; Roux S; Paruta-Tuarez A; Dufort S; Brauer E; Marais A; Truillet C; Sancey L; Perriat P; Lux F; Tillement O
Cancer Nanotechnol; 2014; 5(1):4. PubMed ID: 26561512
[TBL] [Abstract][Full Text] [Related]
16. Nanozymes with Peroxidase-like Activity for Ferroptosis-Driven Biocatalytic Nanotherapeutics of Glioblastoma Cancer: 2D and 3D Spheroids Models.
Carvalho SM; Mansur AAP; da Silveira IB; Pires TFS; Victória HFV; Krambrock K; Leite MF; Mansur HS
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376150
[TBL] [Abstract][Full Text] [Related]
17. [Ultrasmall nanoparticles for radiotherapy: AGuIX].
Lux F; Detappe A; Dufort S; Sancey L; Louis C; Carme S; Tillement O
Cancer Radiother; 2015 Oct; 19(6-7):508-14. PubMed ID: 26343033
[TBL] [Abstract][Full Text] [Related]
18. Mini-pillar array for hydrogel-supported 3D culture and high-content histologic analysis of human tumor spheroids.
Kang J; Lee DW; Hwang HJ; Yeon SE; Lee MY; Kuh HJ
Lab Chip; 2016 Jun; 16(12):2265-76. PubMed ID: 27194205
[TBL] [Abstract][Full Text] [Related]
19. Microstructured soft devices for the growth and analysis of populations of homogenous multicellular tumor spheroids.
Tartagni O; Borók A; Mensà E; Bonyár A; Monti B; Hofkens J; Porcelli AM; Zuccheri G
Cell Mol Life Sci; 2023 Mar; 80(4):93. PubMed ID: 36929461
[TBL] [Abstract][Full Text] [Related]
20. Correction: Quantifying nanotherapeutic penetration using a hydrogel-based microsystem as a new 3D
Goodarzi S; Prunet A; Rossetti F; Bort G; Tillement O; Porcel E; Lacombe S; Wu TD; Guerquin-Kern JL; Delanoë-Ayari H; Lux F; Rivière C
Lab Chip; 2022 Feb; 22(3):652-653. PubMed ID: 34918015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
